Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Simona Pino

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
BMC Research Notes|October 8, 2013
Severe thrombocytopenia after trastuzumab retreatment: a case reportMaria Simona Pino, Catia Angiolini, Luisa Fioretto
Anticancer Research|July 29, 2016
Progression-free Survival as a Surrogate End-point in Advanced Colorectal Cancer Treated with Antiangiogenic TherapiesFrancesco Montagnani, Greta DI Leonardo, Maria Simona Pino, et al.
The Oncologist|March 2, 2010
Fixed-dose-rate gemcitabine: a viable first-line treatment option for advanced pancreatic and biliary tract cancerMichele Milella, Alain J Gelibter, Maria Simona Pino, et al.
Clinical Neuropsychiatry|January 11, 2023
The Relationship Between Covid-19 Risk Perception and Vaccine Hesitancy in Cancer Patients: The Moderating Role of Externalizing TraitsSimone Cheli, Maria Simona Pino, Gil Goldzweig, et al.
Cancer Research|February 20, 2007
Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expressionMarissa Shrader, Maria Simona Pino, Laura Lashinger, et al.
Expert Opinion on Therapeutic Targets|August 9, 2011
Emerging pathways and future targets for the molecular therapy of pancreatic cancerVanja Vaccaro, Davide Melisi, Emilio Bria, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2009
Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomasMaria Simona Pino, Mari Mino-Kenudson, Bernadette Mandes Wildemore, et al.
Molecular Cancer Therapeutics|January 24, 2007
Molecular correlates of gefitinib responsiveness in human bladder cancer cellsMarissa Shrader, Maria Simona Pino, Gordon Brown, et al.
Lung Cancer (Amsterdam, Netherlands)|December 11, 2007
A phase II study of biweekly paclitaxel (P) and gemcitabine (G), followed by maintenance weekly paclitaxel in elderly patients with advanced non-small cell lung cancer (NSCLC)Maria Simona Pino, Teresa Gamucci, Giovanni Mansueto, et al.
Cancer|June 20, 2007
Gemcitabine-based combinations for inoperable pancreatic cancer: have we made real progress? A meta-analysis of 20 phase 3 trialsEmilio Bria, Michele Milella, Alain Gelibter, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
BMC Research Notes|October 8, 2013
Severe thrombocytopenia after trastuzumab retreatment: a case reportMaria Simona Pino, Catia Angiolini, Luisa Fioretto
Anticancer Research|July 29, 2016
Progression-free Survival as a Surrogate End-point in Advanced Colorectal Cancer Treated with Antiangiogenic TherapiesFrancesco Montagnani, Greta DI Leonardo, Maria Simona Pino, et al.
The Oncologist|March 2, 2010
Fixed-dose-rate gemcitabine: a viable first-line treatment option for advanced pancreatic and biliary tract cancerMichele Milella, Alain J Gelibter, Maria Simona Pino, et al.
Clinical Neuropsychiatry|January 11, 2023
The Relationship Between Covid-19 Risk Perception and Vaccine Hesitancy in Cancer Patients: The Moderating Role of Externalizing TraitsSimone Cheli, Maria Simona Pino, Gil Goldzweig, et al.
Cancer Research|February 20, 2007
Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expressionMarissa Shrader, Maria Simona Pino, Laura Lashinger, et al.
Expert Opinion on Therapeutic Targets|August 9, 2011
Emerging pathways and future targets for the molecular therapy of pancreatic cancerVanja Vaccaro, Davide Melisi, Emilio Bria, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2009
Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomasMaria Simona Pino, Mari Mino-Kenudson, Bernadette Mandes Wildemore, et al.
Molecular Cancer Therapeutics|January 24, 2007
Molecular correlates of gefitinib responsiveness in human bladder cancer cellsMarissa Shrader, Maria Simona Pino, Gordon Brown, et al.
Lung Cancer (Amsterdam, Netherlands)|December 11, 2007
A phase II study of biweekly paclitaxel (P) and gemcitabine (G), followed by maintenance weekly paclitaxel in elderly patients with advanced non-small cell lung cancer (NSCLC)Maria Simona Pino, Teresa Gamucci, Giovanni Mansueto, et al.
Cancer|June 20, 2007
Gemcitabine-based combinations for inoperable pancreatic cancer: have we made real progress? A meta-analysis of 20 phase 3 trialsEmilio Bria, Michele Milella, Alain Gelibter, et al.
Pageof 2